Form 4: Medicine Man Technologies Director Kathy Vrabeck Receives Stock Grant for Board Service

Sentiment:

SEC Form 4 Filing


Director Kathy Vrabeck received 67,308 shares of Medicine Man Technologies (SHWZ) common stock as compensation for board service.

Summary

  • Kathy Vrabeck, a director of Medicine Man Technologies, Inc. (SHWZ), received 67,308 shares of common stock on June 28, 2024.
  • The shares were granted as compensation for her service on the company's board of directors.
  • The aggregate value of the shares was $26,250, based on the closing price of the common stock on the OTCQX Best Market on June 28, 2024.
  • Following the transaction, Vrabeck directly owns 127,266 shares of Medicine Man Technologies.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard compensation practice for a board member, indicating continued engagement and alignment of interests.

Positives

  • The stock grant aligns the director's interests with those of the shareholders.
  • The grant is a form of non-cash compensation, preserving the company's cash reserves.

Future Outlook

There are no forward-looking statements in this document.

Industry Context

Stock grants to board members are a common practice in publicly traded companies, especially smaller ones, to conserve cash while still attracting and retaining qualified individuals.

Stakeholder Impact

  • The stock grant dilutes existing shareholders' equity slightly.
  • The grant incentivizes the director to act in the best interests of the company and its shareholders.

Key Dates

DateDescription
06/28/2024Date of the stock grant transaction.
07/02/2024Date of the Form 4 filing.

Keywords

Medicine Man Technologies, SHWZ, Kathy Vrabeck, Director, Stock Grant, Beneficial Ownership, Form 4, OTCQX

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.